U.S. federal trademark · Serial No. 99060189 · Reg. No. UK00004166468
Pharmaceutical preparations and substances for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders for human use; Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Medical treatment services for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Provision of medical information and services; Information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; Provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Scientific research for medical purposes in the field of the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.